Congenital heart disease

Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy

Eur Heart J Cardiovasc PharmacotherPublished clinical consensus statements

Recommendations

As issued by the authors

  1. an individualized approach to antithrombotic therapy is warranted to properly balance the two risks of thrombosis and bleeding

  2. Adoption of the safest interventional techniques, reduction of the intensity and/or duration of antithrombotic therapies, and attention to the safe levels of clotting factors is generally advised.

Original publication

Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy. Eur Heart J Cardiovasc Pharmacother. Published 26 March 2025. doi:10.1093/ehjcvp/pvaf006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.